DBV Technologies
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
DBV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417345 (+3 more)
- LEI:
- 969500PVBQFWQKVDMD80
- Country:
- France
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Manufacturing
Description
DBV Technologies is a clinical-stage biopharmaceutical company developing treatments for food allergies and other immunological diseases. The company's core technology is Viaskin®, a proprietary investigational platform based on epicutaneous immunotherapy (EPIT). This non-invasive patch technology is designed to re-educate the immune system by delivering minimal amounts of antigens through intact skin. DBV's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergies in pediatric patients. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, with the platform holding potential for applications beyond food allergies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-02 22:30 |
Information relative au nombre total des droits de vote et d’actions composant…
|
French | 149.6 KB | ||
| 2024-08-02 22:30 |
Information regarding the total number of voting rights and total number of sh…
|
English | 191.8 KB | ||
| 2024-07-30 23:30 |
DBV Technologies Announces Filing of 2024 Half-Year Report ? Conditions for Acc…
|
English | 203.0 KB | ||
| 2024-07-30 23:30 |
DBV Technologies publie son Rapport Financier Semestriel 2024 ? Modalités de mi…
|
French | 225.2 KB | ||
| 2024-07-30 22:30 |
DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and…
|
English | 331.2 KB | ||
| 2024-07-30 22:30 |
DBV Technologies présente les dernières avancées du programme Viaskin Peanut ch…
|
French | 342.0 KB | ||
| 2024-07-30 22:27 |
RAPPORT FINANCIER SEMESTRIEL
|
French | 1.2 MB | ||
| 2024-07-29 07:30 |
DBV Technologies to Report Second Quarter 2024 Financial Results and Business U…
|
English | 172.1 KB | ||
| 2024-07-29 07:30 |
DBV Technologies présente ses résultats financiers du premier semestre 2024 et …
|
French | 172.1 KB | ||
| 2024-07-08 22:30 |
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
|
English | 215.4 KB | ||
| 2024-07-08 22:30 |
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
|
French | 214.0 KB | ||
| 2024-06-05 22:30 |
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthc…
|
English | 172.2 KB | ||
| 2024-06-05 22:30 |
DBV Technologies participera à la 45e conférence annuelle Goldman Sachs Global …
|
French | 171.8 KB | ||
| 2024-06-04 22:30 |
Information regarding the total number of voting rights and total number of sh…
|
English | 500.3 KB | ||
| 2024-06-04 22:30 |
Information relative au nombre total des droits de vote et d’actions composant…
|
French | 257.1 KB |
Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DBV Technologies
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DBV Technologies via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-09 | N/A | Other | Other | 2,483,161 | 7,449,483.00 EUR |
Peer Companies
